Current status of intracavernosal injection therapy in erectile dysfunction

Area of Science:

• Urology
• Andrology
• Sexual Medicine

Background:

• Erectile dysfunction (ED) affects the ability to attain or maintain penile erections.
• Intracavernosal injection (ICI) therapy was first introduced in 1982.
• ICI remains a viable treatment option for ED, even with the advent of oral medications.

Conclusions:

• Intracavernosal injection (ICI) is a well-established and effective treatment for erectile dysfunction (ED).
• Careful patient selection and comprehensive counseling are crucial for optimizing ICI outcomes.
• ICI therapy, when appropriately managed, ensures both safety and effectiveness in ED management.